{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:57Z","timestamp":1753891257689,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Metabolic-associated fatty liver disease (MAFLD) is a prevalent chronic liver condition with significant health implications. Fermented Cordyceps Preparation (FCP) has shown promise in managing metabolic disorders, prompting interest in its potential for MAFLD prevention. There is, however, a lack of large-scale clinical evidence regarding its preventive efficacy and long-term safety.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>We aimed to assess the preventive efficacy and safety of FCP, as regards combatting MAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Propensity score matching was used to select 343 FCP users and 1372 non-users with metabolic syndrome, (MS) as recorded in EMR. These two groups were followed for 750 days, to track the incidence of MAFLD. The Kaplan Meier method was used to calculate the cumulative risk of MAFLD events in each subgroup. A Multiple linear regression model was used to compare the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), as between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with non-users, FCP users were associated with a 26% decreased risk of MAFLD (hazard ratio 0.74, 95% confidence interval 0.56\u20130.97). During the follow-up, the changes in both ALT and AST, were insignificantly different between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings highlight the potential of FCP in MAFLD prevention and offer insight into its safety profile, suggesting avenues for further clinical validation and drug repurposing efforts.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1576029","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:40:13Z","timestamp":1747201213000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Preventing metabolic-associated fatty liver disease with fermented cordyceps preparation: an electronic medical record based study"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaozhou","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifeng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaixin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis.","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease.","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome.","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1570161115666170621075619","article-title":"Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome?","volume":"16","author":"Katsiki","year":"2018","journal-title":"Curr Vasc Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3346\/jkms.2008.23.5.789","article-title":"Impact of visceral fat on the metabolic syndrome and nonalcoholic fatty liver disease.","volume":"23","author":"Jeong","year":"2008","journal-title":"J Korean Med Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.","volume":"143","author":"Hamaguchi","year":"2005","journal-title":"Ann Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e745","DOI":"10.1210\/clinem\/dgab644","article-title":"Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: A prospective cohort study.","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis.","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jtcme.2020.02.008","article-title":"Beneficial effects of Chinese herbs in the treatment of fatty liver diseases.","volume":"10","author":"Panyod","year":"2020","journal-title":"J Tradit Complement Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13020-024-00895-0","article-title":"Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway.","volume":"19","author":"Lu","year":"2024","journal-title":"Chin Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1142\/S0192415X11009007","article-title":"Cordyceps sobolifera extract ameliorates lipopolysaccharide-induced renal dysfunction in the rat.","volume":"39","author":"Wu","year":"2011","journal-title":"Am J Chin Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway.","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies.","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med."},{"key":"B17","first-page":"767","article-title":"Cordyceps sinensis biomass produced by submerged fermentation in high-fat diet feed rats normalizes the blood lipid and the low testosterone induced by diet.","volume":"11","author":"Freire Dos Santos","year":"2012","journal-title":"EXCLI J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0232972","DOI":"10.1371\/journal.pone.0232972","article-title":"Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.","volume":"15","author":"Chen","year":"2020","journal-title":"PLoS One."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1016\/j.lfs.2003.11.003","article-title":"The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin.","volume":"74","author":"Lo","year":"2004","journal-title":"Life Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1039\/c9fo00482c","article-title":"Protective effects of polysaccharides from Cordyceps gunnii mycelia against cyclophosphamide-induced immunosuppression to TLR4\/TRAF6\/NF-\u03baB signalling in BALB\/c mice.","volume":"10","author":"Meng","year":"2019","journal-title":"Food Funct."},{"key":"B21","first-page":"76","article-title":"Clinical observation of bailing capsule in treating hepatic fibrosis after hepatitis.","volume":"18","author":"Liu","year":"2011","journal-title":"Information J Chinese Med."},{"key":"B22","first-page":"979","article-title":"Clinical observation of Jinshui Bao capsule combined with Atomolan and ursodeoxycholic acid in the treatment of non-alcoholic fatty liver disease.","volume":"17","author":"Liu","year":"2010","journal-title":"Practical Prevent Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/07315724.2020.1743211","article-title":"Safety assessment of HEA-enriched cordyceps cicadae mycelium: A randomized clinical trial.","volume":"40","author":"Tsai","year":"2021","journal-title":"J Am Coll Nutr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1038\/s41598-020-62609-4","article-title":"Association between hepatitis b virus infection and metabolic syndrome in southwest China: A cross-sectional study.","volume":"10","author":"Yan","year":"2020","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: An American heart association\/national heart, lung, and blood institute scientific statement.","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation."},{"key":"B26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mce.2015.02.018","article-title":"Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?","volume":"418","author":"Asrih","year":"2015","journal-title":"Mol Cell Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.1038\/s41598-022-11219-3","article-title":"Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hepatic steatosis.","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/jps.3030460211","article-title":"Cordyceps sinesis (Berkeley) saccardo: Structure of cordycepic acid.","volume":"46","author":"Chatterjee","year":"1957","journal-title":"J Am Pharm Assoc Am Pharm Assoc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1039\/d1fo00596k","article-title":"A polysaccharide from natural Cordyceps sinensis regulates the intestinal immunity and gut microbiota in mice with cyclophosphamide-induced intestinal injury.","volume":"12","author":"Chen","year":"2021","journal-title":"Food Funct."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1042\/CS20190331","article-title":"Ergosterol attenuates cigarette smoke extract-induced COPD by modulating inflammation, oxidative stress and apoptosis in vitro and in vivo.","volume":"133","author":"Sun","year":"2019","journal-title":"Clin Sci (Lond)."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1576029\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:40:15Z","timestamp":1747201215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1576029\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":31,"alternative-id":["10.3389\/fmed.2025.1576029"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1576029","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"article-number":"1576029"}}